Early evaluation and value-based pricing of regenerative medicine technologies.
about
The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the LiteratureEarly decision-analytic modeling - a case study on vascular closure devices.The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance.Evaluation as institution: a contractarian argument for needs-based economic evaluation.
P2860
Early evaluation and value-based pricing of regenerative medicine technologies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Early evaluation and value-based pricing of regenerative medicine technologies.
@en
Early evaluation and value-based pricing of regenerative medicine technologies.
@nl
type
label
Early evaluation and value-based pricing of regenerative medicine technologies.
@en
Early evaluation and value-based pricing of regenerative medicine technologies.
@nl
prefLabel
Early evaluation and value-based pricing of regenerative medicine technologies.
@en
Early evaluation and value-based pricing of regenerative medicine technologies.
@nl
P2860
P356
P1476
Early evaluation and value-based pricing of regenerative medicine technologies
@en
P2093
Florian Koerber
Wolf Rogowski
P2860
P304
P356
10.2217/RME.13.69
P577
2013-11-01T00:00:00Z